InDex Pharmaceuticals Holding AB (publ) announced that after more than seven years as CEO, Peter Zerhouni has decided to leave his position. The company's CFO Johan Giléus has been appointed acting CEO while a new CEO is being recruited, and he will also continue as CFO. Peter Zerhouni will be available to the board during his notice period.